80 FR 249 pgs. 81233-81234 - Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments; Correction
Type: PRORULEVolume: 80Number: 249Pages: 81233 - 81234
Pages: 81233, 81234Docket number: [Docket No. FDA-2015-D-3719]
FR document: [FR Doc. 2015-32686 Filed 12-28-15; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1271
[Docket No. FDA-2015-D-3719]
Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments; Correction
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notification of public hearing; request for comments; correction.
SUMMARY:
The Food and Drug Administration (FDA or Agency) is correcting a notification of a public hearing entitled "Draft Guidances Relating to the Regulation of Human Cells, Tissues, or Cellular or Tissue-Based Products; Public Hearing; Request for Comments" that appeared in the Federal Register of October 30, 2015 (80 FR 66845). The document announced a public hearing to obtain input on four recently issued draft guidances relating to the regulation of human cells, tissues, or cellular or tissue-based products (HCT/Ps). The document published with conflicting information about who must register for the public hearing. This document corrects that error.
FOR FURTHER INFORMATION CONTACT:
Lori Jo Churchyard, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993, 240-402-7911.
SUPPLEMENTARY INFORMATION:
In FR Doc. 2015-27703, appearing on pages 66845 and 66847 in the Federal Register of Friday, October 30, 2015, the following corrections are made:
1. On page 66845, in the third column under DATES , the third sentence is revised to read: "Persons seeking to attend (including FDA employees) or to present at the public hearing must register by January 8, 2016."
[top] 2. On page 66847, in the first column under section IV. Attendance and Registration, the third sentence is revised to read: "Individuals who wish to attend (including FDA employees) or present at the public hearing must
Dated: December 21, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-32686 Filed 12-28-15; 8:45 am]
BILLING CODE 4164-01-P